INSPIREMD INC. - COMMON STOCK

InspireMD Announces May 16, 2023 as New Date for First Quarter 2023 Results Conference Call and Webcast

12 May 2023 16:05:00 By Nasdaq GlobeNewswire

InspireMD Announces May 15th as New Date for First Quarter 2023 Financial Results and Corporate Business Update

05 May 2023 08:00:00 By Nasdaq GlobeNewswire

InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform

01 May 2023 08:00:02 By Nasdaq GlobeNewswire

InspireMD to Report First Quarter 2023 Financial Results on May 9, 2023, and Provide Corporate Business Update

27 Apr 2023 08:00:01 By Nasdaq GlobeNewswire

InspireMD Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

30 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer

20 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

InspireMD to Report Fourth Quarter and Full-Year 2022 Financial Results on March 30, 2023, and Provide a Corporate Business Update

02 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

InspireMD Announces Hiring of Medical Device Commercial Veteran Shane Gleason as General Manager of North America and VP of Global Marketing

14 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

InspireMD Reports Third Quarter 2022 Financial Results and Provides Business Update

08 Nov 2022 07:00:03 By Nasdaq GlobeNewswire

InspireMD to Report Third Quarter 2022 Financial Results on November 8, 2022, and Provide Corporate Business Update

25 Oct 2022 08:00:01 By Nasdaq GlobeNewswire